Innovative Strategies for Long-Term Management of Rosacea - Report - MDSpire

Innovative Strategies for Long-Term Management of Rosacea

  • By

  • Martin Schaller

  • Belinda Welsh

  • Giuseppe Micali

  • Jerry Tan

  • James Del Rosso

  • Julie Harper

  • Thomas Dirschka

  • Soyun Cho

  • Luiz M. C. Almeida

  • Khen Kon

  • Wioletta Barańska-Rybak

  • Johannes Dayrit

  • Linda Stein Gold

  • December 12, 2025

  • 0 min

Share

Clinical Report: Innovative Strategies for Long-Term Management of Rosacea

Overview

The REACH Global Scientific Committee has developed a comprehensive management pathway for rosacea, emphasizing the importance of patient communication and long-term care strategies. This approach aims to enhance adherence to treatment and improve quality of life for patients suffering from this chronic condition.

Background

Rosacea is a chronic skin condition that can significantly impact patients' quality of life. Despite existing guidelines, there is a noted gap in their uptake among healthcare professionals, necessitating a streamlined approach to management. The REACH initiative addresses these challenges by providing a structured framework for diagnosis, treatment, and maintenance of rosacea.

Data Highlights

No numerical data provided in the source material.

Key Findings

  • The REACH GSC identified key steps in the management pathway: self-management, diagnosis, treatment selection, and maintenance.
  • Effective communication between patients and healthcare professionals is crucial for understanding and managing rosacea.
  • Long-term management strategies are essential due to the chronic nature of rosacea.
  • Clinical trials often have time constraints that do not reflect the need for ongoing maintenance therapy.
  • Recent literature emphasizes a phenotype-first approach to treatment, integrating pharmacologic and holistic measures.

Clinical Implications

Healthcare professionals should prioritize clear communication with patients about the chronic nature of rosacea to enhance engagement in their care. Implementing a structured management pathway can improve adherence to treatment and overall patient outcomes.

Conclusion

The REACH initiative provides a valuable framework for the long-term management of rosacea, addressing both clinical and patient-centered needs. By fostering better communication and understanding, healthcare professionals can significantly improve the quality of life for patients with this condition.

References

  1. Ophthalmology Management, 2018 -- Relieving severe rosacea with IPL
  2. Optometric Management, 2026 -- Recognizing and Treating Ocular Rosacea in Darker Skin Tones
  3. National Rosacea Society, 2025 -- National Rosacea Society Introduces Updated Rosacea Treatment Algorithms
  4. JAMA Dermatology, 2025 -- Efficacy, Safety, and Tolerability of Oral DFD-29, a Low-Dose Formulation of Minocycline, in Rosacea
  5. Optometric Management — Recognizing and Treating Ocular Rosacea in Darker Skin Tones
  6. Optometric Management — Recognizing and Treating Ocular Rosacea in Darker Skin Tones
  7. National Rosacea Society Introduces Updated Rosacea Treatment Algorithms | Rosacea.org
  8. Efficacy, Safety, and Tolerability of Oral DFD-29, a Low-Dose Formulation of Minocycline, in Rosacea: Two Phase 3 Randomized Clinical Trials | Rosacea | JAMA Dermatology | JAMA Network
  9. How to Optimize Rosacea Treatment for Better Patient Outcomes: An Opinion Piece - PMC

Original Source(s)

Related Content